Study of alpha defensin in coronary artery disease and type 2 diabetes mellitus on the background of metabolic syndrome

Study of alpha defensin in coronary artery disease and type 2 diabetes mellitus on the background of metabolic syndrome

Background. The prevalence of metabolic syndrome (MS), a cluster of risk factors for type 2 diabetes mellitus (DM) and coronary artery disease (CAD), is increasing annually. MS is associated with an almost 2-fold increase in the risk of cardiovascular complications and 1.5-fold increase in all-cause...

Full description

Bibliographic Details
Main Authors: N.V. Chmyr, R.Ya. Dutka, Kh.Ya. Abrahamovych, Y.M. Fedechko, M.M. Kurban
Format: Article
Language:English
Published: Zaslavsky O.Yu. 2022-11-01
Series:Mìžnarodnij Endokrinologìčnij Žurnal
Subjects:
alpha defensin
coronary artery disease
type 2 diabetes mellitus
Online Access:https://iej.zaslavsky.com.ua/index.php/journal/article/view/1211

Internet

https://iej.zaslavsky.com.ua/index.php/journal/article/view/1211

Similar Items